Skip to main content

Table 1 Primary antibodies and dilutions used for the immunohistochemical analyses and results

From: First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report

Antibody to Manufacturer Dilution Results
ER Ventana ready-to-use Negative
PgR Ventana ready-to-use Negative
HER2 Dako 1:1000 Negative
S100 protein Dako 1:2000 Positive
EMA Ventana ready-to-use Positive
GCDFP15 Signet 1:20 Negative
P53 Novocastra 1:200 Positive
AACT Dako 1:1000 Positive
Actin Dako 1:400 Negative
Maspin Pharmingen 1:500 Negative
Calponin BioGenex 1:400 Negative
  1. ER, estrogen receptor; PgR, progesterone receptor; HER2, human epidermal growth factor receptor 2; EMA, epithelial membrane antigen; GCDFP15, gross cystic disease fluid protein-15; AACT, alpha-1-antichymotrypsin.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us